Only three out of the 11 sectors in the S&P 500 traded lower Monday afternoon, as the tech trade was under renewed pressure.
Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...
U.S. stocks trimmed some losses in the final hour of trading but remained lower, with tech stocks leading the decline. The ...
Bitcoin edged 2.6% lower Monday afternoon, trading at as low as $85,199 — the lowest level since Dec. 2 — according to the ...
Investors looking for a Supreme Court decision on President Donald Trump’s tariffs may now need to look at next year — but ...
On Monday, the Vanguard Value ETF, an exchange-traded fund tracking large-cap value stocks, traded at its best level relative ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果